tomeko

Autosomal dominant deafness - onychodystrophy syndrome

Just diagnosed with Autosomal dominant deafness - onychodystrophy syndrome?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Autosomal dominant deafness - onychodystrophy syndrome, look for clinical trials, and connect with others living with it — all in one place.

Open the full Autosomal dominant deafness - onychodystrophy syndrome hub →

Overview

Autosomal dominant deafness - onychodystrophy syndrome is a rare condition. Also known as Autosomal dominant hearing loss-onychodystrophy syndrome, DDOD syndrome. Tomeko brings together the specialists, research, clinical trials, treatments and community for Autosomal dominant deafness - onychodystrophy syndrome so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:79499 · OMIM 124480 · ICD-10 Q87.8 · GARD 0004732

Find care for Autosomal dominant deafness - onychodystrophy syndrome

Authoritative references for Autosomal dominant deafness - onychodystrophy syndrome

Common questions

I was just diagnosed with Autosomal dominant deafness - onychodystrophy syndrome — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Autosomal dominant deafness - onychodystrophy syndrome, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Autosomal dominant deafness - onychodystrophy syndrome?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Autosomal dominant deafness - onychodystrophy syndrome, filtered to your area.

Are there clinical trials for Autosomal dominant deafness - onychodystrophy syndrome?

Tomeko shows live, recruiting studies for Autosomal dominant deafness - onychodystrophy syndrome from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com